A consortium focused on preventing cancer through innovative therapies.
iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium
This study is looking for new ways to help people who are at high risk of getting cancer stay healthy, by testing safer and more effective prevention methods that are easy for them to accept.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10914677 on NIH RePORTER |
What this research studies
This research aims to develop and test new strategies for cancer prevention, particularly targeting individuals at high risk for developing cancer. The project brings together a diverse team of experts, including clinical trialists and molecular biologists, to conduct early phase clinical trials. By exploring safer and more effective preventive therapies, the goal is to identify interventions that are acceptable to healthy individuals and can significantly reduce cancer incidence. The consortium has a strong track record, having previously conducted numerous cancer prevention trials.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at high risk for cancer, including those with a family history of cancer or specific genetic predispositions.
Not a fit: Patients who are currently diagnosed with advanced cancer may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective cancer prevention therapies that significantly lower the risk of developing cancer.
How similar studies have performed: Previous clinical trials have shown promise in cancer prevention using various interventions, indicating that this approach has potential for success.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Vilar Sanchez, Eduardo — University of Tx Md Anderson Can Ctr
- Study coordinator: Vilar Sanchez, Eduardo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.